Innovation: Sugars harnessed to fight disease: A glycobiology company spun off from Oxford University plans to use its expertise to develop more effective drugs

A UK company is aiming to capitalise on research that shows sugars play a leading role in many human diseases.

Oxford Glycosystems was spun out of Oxford University in 1988 to develop equipment for analysing the structure of sugars. Now it intends to use its world-leading knowledge as the basis of a drugs discovery division.

The emerging science of glycobiology, the study of the molecular activity of sugars in the body, offers the potential to develop new drugs to combat diseases including arthritis, asthma, cancer and malaria, and the ability to 'turbo boost' existing drugs by targeting them for specific tissues.

Dr Robert Burns has just joined Oxford Glycosystems from British Biotechnology to set up the drugs division. The company, which has so far raised dollars 30m (pounds 19m) in venture capital, wants to raise the same amount again to fund this development. The company has completed preparations for a New York listing on Nasdaq. But Dr Burns says it will be able to raise the money privately if market conditions remain unsuitable for a flotation.

The driving force behind Oxford Glycosystems is the glycobiology pioneer, Professor Raymond Dwek, who has overthrown the orthodoxy that there are only two significant types of biological molecule: proteins and DNA.

Together with colleagues at Oxford University's Glycobiology Institute, Professor Dwek has shown that complex branching chains of sugar molecules on the outside of proteins actually control the functioning of the proteins. Proteins depend on their sugars to recognise and interact with one another. Research suggests that many diseases are the result of abnormal sugar chains and that they might be treated by manipulating the sugars.

For example, rheumatoid arthritis is associated with abnormal distribution of sugars on the patient's antibodies. It is also thought that these sugars play a key role in the movement of cancer cells around the body to start secondary tumours. Drugs designed to bind the sugars would prevent the cancer spreading.

Working with the pharmaceuticals company, Monsanto, the Glycobiology Institute has developed an Aids drug, Butyl-DNJ, which is now in the second stage of clinical trials. The drug works by disrupting the sugars on the surface of HIV, the virus that causes Aids. HIV relies on its specific sugar patterns to recognise and infect human cells.

Just as instruments for elucidating the structure of proteins and DNA were vital to the commercialisation of molecular biology, Oxford Glycosystems has opened up the potential of glycobiology by developing equipment and techniques for analysing quickly the complex structures of sugars.

The company has developed three different machines and has an annual turnover of dollars 5m. Customers include Zeneca, SmithKline Beecham, Glaxo and Wellcome. As the company set up by the university to commercialise its glycobiology research (the University has 5 per cent of the equity), Oxford Glycosystems has exclusive rights to work carried out at the Institute on the analysis and preparation of sugars.

Dr Burns says Oxford Glycosystems will follow three approaches in drug discovery. First, it will design new sugars and test them for pharmacological effects. Second, it will aim to enhance the effectiveness of existing drugs by linking sugars to them so that they can be targeted at specific tissues. For example, cytotoxic drugs used to treat liver cancer also kill normal cells in other parts of the body. By adding a sugar, the drugs would only be able to bind to the specific sugar on the outside of the tumour cells.

Dr Burns believes this approach would be popular with pharmaceutical companies that have lucrative drugs nearing the end of their patent protection. Such modified drugs would not only be more effective, they would be patentable, cheap and fast to get to market.

The third area of research will be the discovery and development of new drugs, starting with cancer treatment.

(Photograph omitted)

people And here is why...
Arts and Entertainment
Amazon has added a cautionary warning to Tom and Jerry cartoons on its streaming service
voicesBy the man who has
Arsene Wenger tried to sign Eden Hazard
footballAfter 18 years with Arsenal, here are 18 things he has still never done as the Gunners' manager
Life and Style
The new Windows 10 Start Menu
Arts and Entertainment
Kristen Stewart and Robert Pattinson star in The Twilight Saga but will not be starring in the new Facebook mini-movies
tvKristen Stewart and Stephenie Meyer will choose female directrs
Arts and Entertainment
Hilary North's 'How My Life Has Changed', 2001
books(and not a Buzzfeed article in sight)
ebooksAn unforgettable anthology of contemporary reportage
William Hague
people... when he called Hague the county's greatest
More than 90 years of car history are coming to an end with the abolition of the paper car-tax disc
newsThis and other facts you never knew about the paper circle - completely obsolete today
Arts and Entertainment
There has been a boom in ticket sales for female comics, according to an industry survey
comedyFirst national survey reveals Britain’s comedic tastes
Arts and Entertainment
Twerking girls: Miley Cyrus's video for 'Wrecking Ball'
arts + ents
Arts and Entertainment
Ed Sheeran performs at his Amazon Front Row event on Tuesday 30 September
musicHe spotted PM at private gig
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Trainee Recruitment Consultant - Birmingham - Real Staffing

£18000 - £23000 per annum + Commission: SThree: Real Staffing are currently lo...

Trust Accountant - Kent

NEGOTIABLE: Austen Lloyd: TRUST ACCOUNTANT - KENTIf you are a Chartered Accou...

Graduate Recruitment Consultant - 2013/14 Grads - No Exp Needed

£18000 - £20000 per annum + OTE £30000: SThree: SThree are a global FTSE 250 b...

Law Costs

Highly Competitive Salary: Austen Lloyd: CITY - Law Costs Draftsperson - NICHE...

Day In a Page

Ebola outbreak: The children orphaned by the virus – then rejected by surviving relatives over fear of infection

The children orphaned by Ebola...

... then rejected by surviving relatives over fear of infection
Pride: Are censors pandering to homophobia?

Are censors pandering to homophobia?

US film censors have ruled 'Pride' unfit for under-16s, though it contains no sex or violence
The magic of roundabouts

Lords of the rings

Just who are the Roundabout Appreciation Society?
Why do we like making lists?

Notes to self: Why do we like making lists?

Well it was good enough for Ancient Egyptians and Picasso...
Hong Kong protests: A good time to open a new restaurant?

A good time to open a new restaurant in Hong Kong?

As pro-democracy demonstrators hold firm, chef Rowley Leigh, who's in the city to open a new restaurant, says you couldn't hope to meet a nicer bunch
Paris Fashion Week: Karl Lagerfeld leads a feminist riot on 'Boulevard Chanel'

Paris Fashion Week

Lagerfeld leads a feminist riot on 'Boulevard Chanel'
Bruce Chatwin's Wales: One of the finest one-day walks in Britain

Simon Calder discovers Bruce Chatwin's Wales

One of the finest one-day walks you could hope for - in Britain
10 best children's nightwear

10 best children's nightwear

Make sure the kids stay cosy on cooler autumn nights in this selection of pjs, onesies and nighties
Manchester City vs Roma: Five things we learnt from City’s draw at the Etihad

Manchester City vs Roma

Five things we learnt from City’s Champions League draw at the Etihad
Martin Hardy: Mike Ashley must act now and end the Alan Pardew reign

Trouble on the Tyne

Ashley must act now and end Pardew's reign at Newcastle, says Martin Hardy
Isis is an hour from Baghdad, the Iraq army has little chance against it, and air strikes won't help

Isis an hour away from Baghdad -

and with no sign of Iraq army being able to make a successful counter-attack
Turner Prize 2014 is frustratingly timid

Turner Prize 2014 is frustratingly timid

The exhibition nods to rich and potentially brilliant ideas, but steps back
Last chance to see: Half the world’s animals have disappeared over the last 40 years

Last chance to see...

The Earth’s animal wildlife population has halved in 40 years
So here's why teenagers are always grumpy - and it's not what you think

Truth behind teens' grumpiness

Early school hours mess with their biological clocks
Why can no one stop hackers putting celebrities' private photos online?

Hacked photos: the third wave

Why can no one stop hackers putting celebrities' private photos online?